# Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer

> **NCT00997009** · PHASE2 · UNKNOWN · sponsor: **National Cancer Institute, Naples** · enrollment: 108 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** paclitaxel
- **DRUG:** carboplatin
- **DRUG:** cetuximab

## Key facts

- **NCT ID:** NCT00997009
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997009, "Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00997009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*